Sommaire

• • ·Table of Contents

    Page :A1

    
• • ·Editorial Board

    Page :A5

    
• • ·Information for Readers

    Page :A6

    

• Trial Design

  • ·Reclassification of cardiovascular risk using integrated clinical and molecular biosignatures: Design of and rationale for the Measurement to Understand the Reclassification of Disease of Cabarrus and Kannapolis (MURDOCK) Horizon 1 Cardiovascular Disease Study

    Page :371

    Svati H. Shah, Christopher B. Granger, Elizabeth R. Hauser, William E. Kraus, Jie-Lena Sun, Karen Pieper, Charlotte L. Nelson, Elizabeth R. Delong, Robert M. Califf, L. Kristin Newby, MURDOCK Horizon 1 Cardiovascular Disease Investigators f

    Résumé Résumé Plan Plan  
  • ·Rationale and design of a randomized, double-blind trial comparing the effects of a 3-month clopidogrel-aspirin regimen versus aspirin alone for the treatment of high-risk patients with acute nondisabling cerebrovascular event

    Page :380

    Yongjun Wang, S. Claiborne Johnston, CHANCE Investigators c

    Résumé Résumé Plan Plan  
  • ·The efficacy and safety of clopidogrel in vascular surgery patients with immediate postoperative asymptomatic troponin T release for the prevention of late cardiac events: Rationale and design of the Dutch Echocardiographic Cardiac Risk Evaluation Applying Stress Echo-VII (DECREASE-VII) trial

    Page :387-393

    Jan-Peter van Kuijk, Michiel T. Voute, Willem-Jan Flu, Olaf Schouten, Michel Chonchol, Sanne E. Hoeks, Eric E. Boersma, Hence J.M. Verhagen, Jeroen J. Bax, Don Poldermans

    Résumé Résumé Plan Plan  

• Progress in Cardiology

  • ·Diastolic dysfunction: Improved understanding using emerging imaging techniques

    Page :394-404

    Daniel Daneshvar, Janet Wei, Kirsten Tolstrup, Louise E.J. Thomson, Chrisandra Shufelt, C. Noel Bairey Merz

    Résumé Résumé Plan Plan  

• Clinical Investigations

  • ·Influence of transfer-in rates on quality of care and outcomes at receiving hospitals in patients with non–ST-segment elevation myocardial infarction

    Page :405-411

    Rajendra H. Mehta, Anita Y. Chen, E. Magnus Ohman, W. Brian Gibler, Eric D. Peterson, Matthew T. Roe, CRUSADE National Quality Improvement Initiative Investigators

    Résumé Résumé Plan Plan
  • ·Elevated admission glucose is associated with increased long-term mortality in myocardial infarction patients, irrespective of the initially applied reperfusion strategy

    Page :412-419

    Maarten de Mulder, Jan-Hein Cornel, Tjeerd van der Ploeg, Eric Boersma, Victor A. Umans

    Résumé Résumé Plan Plan  
  • ·Temporal trend of in-hospital major bleeding among patients with non ST-elevation acute coronary syndromes

    Page :420-427

    Basem Elbarouni, Omran Elmanfud, Raymond T. Yan, Keith A.A. Fox, Jan M. Kornder, Barry Rose, Frederick A. Spencer, Robert C. Welsh, Graham C. Wong, Shaun G. Goodman, Andrew T. Yan

    Résumé Résumé Plan Plan  
  • ·Results of a phase 1, randomized, double-blind, placebo-controlled trial of bone marrow mononuclear stem cell administration in patients following ST-elevation myocardial infarction

    Page :428-434

    Jay H. Traverse, David H. McKenna, Karen Harvey, Beth C. Jorgenso, Rachel E. Olson, Nancy Bostrom, Diane Kadidlo, John R. Lesser, Vikrant Jagadeesan, Ross Garberich, Timothy D. Henry

    Résumé Résumé Plan Plan  
  • ·?-Blocker use following myocardial infarction: Low prevalence of evidence-based dosing

    Page :435

    Jeffrey J. Goldberger, Robert O. Bonow, Michael Cuffe, Alan Dyer, Yves Rosenberg, Robert O'Rourke, Prediman K. Shah, Sidney C. Smith, PACE-MI Investigators

    Résumé Résumé Plan Plan  
  • ·A severity scoring system for risk assessment of patients with cardiogenic shock: A report from the SHOCK Trial and Registry

    Page :443-450

    Lynn A. Sleeper, Harmony R. Reynolds, Harvey D. White, John G. Webb, Vladimir Džavík, Judith S. Hochman

    Résumé Résumé Plan Plan  
  • ·Quality of life among patients undergoing transcatheter aortic valve implantation

    Page :451-457

    Markus Krane, Marcus-André Deutsch, Sabine Bleiziffer, Lisa Schneider, Hendrik Ruge, Domenico Mazzitelli, Christian Schreiber, Gernod Brockmann, Bernhard Voss, Robert Bauernschmitt, Rüdiger Lange

    Résumé Résumé Plan Plan  
  • ·Effects of smoking intensity and cessation on inflammatory markers in a large cohort of active smokers

    Page :458-463

    Asha Asthana, Heather M. Johnson, Megan E. Piper, Michael C. Fiore, Timothy B. Baker, James H. Stein

    Résumé Résumé Plan Plan
  • ·Serum magnesium and risk of sudden cardiac death in the Atherosclerosis Risk in Communities (ARIC) Study

    Page :464-470

    James M. Peacock, Tetsuya Ohira, Wendy Post, Nona Sotoodehnia, Wayne Rosamond, Aaron R. Folsom

    Résumé Résumé Plan Plan  
  • ·Prevalence and prognosis of left ventricular diastolic dysfunction in the elderly: The PROTEGER Study

    Page :471-478

    Yi Zhang, Michel E. Safar, Pierre Iaria, Davide Agnoletti, Athanase D. Protogerou, Jacques Blacher

    Résumé Résumé Plan Plan  
  • ·Fibrinogen and left ventricular myocardial systolic function: The Multi-Ethnic Study of Atherosclerosis (MESA)

    Page :479-486

    Raymond T. Yan, Veronica Fernandes, Andrew T. Yan, Mary Cushman, Alban Redheuil, Russell Tracy, Jens Vogel-Claussen, Hossein Bahrami, Khurram Nasir, David A. Bluemke, Joao A.C. Lima

    Résumé Résumé Plan Plan
  • ·Protective effects of the angiotensin II receptor blocker telmisartan on epirubicin-induced inflammation, oxidative stress, and early ventricular impairment

    Page :487.e1

    Christian Cadeddu, Alessandra Piras, Giovanni Mantovani, Martino Deidda, Mariele Dessì, Clelia Madeddu, Elena Massa, Giuseppe Mercuro

    Résumé Résumé Plan Plan  
  • ·Left ventricular dysfunction as a risk factor for cardiovascular and noncardiovascular hospitalizations in African Americans

    Page :488-495

    Saul Blecker, Kunihiro Matsushita, Ervin Fox, Stuart D. Russell, Edgar R. Miller, Herman Taylor, Frederick Brancati, Josef Coresh

    Résumé Résumé Plan Plan  
  • ·Renin-angiotensin system–related gene polymorphisms are associated with risk of atrial fibrillation

    Page :496-505

    Peilin Xiao, Zhiyu Ling, Kamsang Woo, Huaan Du, Li Su, Zengzhang Liu, Yuehui Yin

    Résumé Résumé Plan Plan  
  • ·Protective effect of the CYP2C19 *17 polymorphism with increased activation of clopidogrel on cardiovascular events

    Page :506-512

    Klaus A. Tiroch, Dirk Sibbing, Werner Koch, Tobias Roosen-Runge, Julinda Mehilli, Albert Schömig, Adnan Kastrati

    Résumé Résumé Plan Plan  
  • ·The additive blood pressure lowering effects of exercise intensity on post-exercise hypotension

    Page :513-520

    John D. Eicher, Carl M. Maresh, Gregory J. Tsongalis, Paul D. Thompson, Linda S. Pescatello

    Résumé Résumé Plan Plan  
  • ·Predictors of 90-day readmission among patients with acute severe hypertension. The cross-sectional observational Studying the Treatment of Acute hyperTension (STAT) study

    Page :521

    Joel M. Gore, Eric Peterson, Alpesh Amin, Frederick A. Anderson, Joseph F. Dasta, Phillip D. Levy, Brian J. O'Neil, Gene Yong Sung, Joseph Varon, Allison Wyman, Christopher B. Granger, STAT Investigators i

    Résumé Résumé Plan Plan  
  • ·Regional myocardial blood flow measured by stress multidetector computed tomography as a predictor of recovery of left ventricular function after coronary artery bypass grafting

    Page :528-534

    Fumiaki Shikata, Hiroshi Imagawa, Kanji Kawachi, Teruhito Kido, Akira Kurata, Yuma Inoue, Kohei Hosokawa, Michinobu Nagao, Hiroshi Higashino, Teruhito Mochizuki, Masahiro Ryugo, Mitsugi Nagashima

    Résumé Résumé Plan Plan  
  • ·Real-world outcome of coronary bifurcation lesions in the drug-eluting stent era: Results from the 4,314-patient Italian Society of Invasive Cardiology (SICI-GISE) Italian Multicenter Registry on Bifurcations (I-BIGIS)

    Page :535

    Enrico Romagnoli, Stefano De Servi, Corrado Tamburino, Antonio Colombo, Francesco Burzotta, Patrizia Presbitero, Leonardo Bolognese, Leonardo Paloscia, Paolo Rubino, Gennaro Sardella, Carlo Briguori, Federica Ettori, Gianfranco Franco, Domenico Di Girolamo, Imad Sheiban, Luigi Piatti, Cesare Greco, Sonia Petronio, Bruno Loi, Ernesto Lioy, Alberto Benassi, Aldo Patti, Achille Gaspardone, Davide Capodanno, Giuseppe G.L. Biondi-Zoccai, Giuseppe Sangiorgi, I-BIGIS Study Group Milan, Italy

    Résumé Résumé Plan Plan  
  • ·Prognostic significance of high on-clopidogrel platelet reactivity after percutaneous coronary intervention: Systematic review and meta-analysis

    Page :543-551

    Dániel Aradi, András Komócsi, András Vorobcsuk, Orsolya Rideg, Margit T?kés-Füzesi, Tamás Magyarlaki, Iván Gábor Horváth, Victor L. Serebruany

    Résumé Résumé Plan Plan  
  • ·Comparison of rotational with conventional coronary angiography

    Page :552-563

    Klaus Empen, Eberhard Kuon, Astrid Hummel, Chris Gebauer, Marcus Dörr, Raik Könemann, Wolfgang Hoffmann, Alexander Staudt, Kerstin Weitmann, Thorsten Reffelmann, Stephan B. Felix

    Résumé Résumé Plan Plan  
  • ·Vulnerable disease may induce neointimal coverage after silorimus-eluting stent implantation

    Page :564-569

    Masami Nishino, Shiro Hoshida, Masayuki Taniike, Hiroyasu Kato, Yasuyuki Egami, Ryu Shutta, Hitoshi Yamaguchi, Kenjiro Tanaka, Jun Tanouchi, Yoshio Yamada

    Résumé Résumé Plan Plan  

• Letters to the Editor

  • ·Triple antiplatelet therapy reduces ischemic events after drug-eluting stent implantation: Drug-Eluting stenting followed by Cilostazol treatment REduces Adverse Serious cardiac Events (DECREASE registry)

    Page :e21

    Gen-Min Lin, Kai-Min Chu, Chih-Lu Han

    
  • ·Response to letter regarding the article “Triple antiplatelet therapy reduces ischemic events after drug-eluting stent implantation; Drug-Eluting stenting followed by Cilostazol treatment REduces Adverse Serious cardiac Events (DECREASE registry)”

    Page :e23

    Seung-Whan Lee, Seong-Wook Park

    
  • ·Low-molecular-weight heparin versus unfractionated heparin in acute ST-segment elevation myocardial infarction patients undergoing primary percutaneous coronary intervention with drug-eluting stents

    Page :e25

    Obiora F. Anusionwu, Nirav Shah

    
  • ·Response to letter regarding the article “Low-molecular-weight heparin versus unfractionated heparin in acute ST-segment elevation myocardial infarction patients undergoing primary percutaneous coronary intervention with drug-eluting stents”

    Page :e27

    Seung-Woon Rha, Yong-Jian Li, Kang-Yin Chen, Kanhaiya L. Poddar, Zhe Jin, Yoshiyasu Minami, Lin Wang, Qun Dang, Guang-Ping Li, Sureshkumar Ramasamy, Ji-Young Park, Cheol Ung Choi, Jin-Won Kim, Eung Ju Kim, Chang Gyu Park, Hong Seog Seo, Dong Joo Oh, Myung Ho Jeong, Young Keun Ahn, Taek Jong Hong, Jong-Seon Park, Young Jo Kim, Seung Ho Hur, In Whan Seong, Jei Keon Chae, Myeong Chan Cho, Jang Ho Bae, Dong Hoon Choi, Yang Soo Jang, In Ho Chae, Hyo Soo Kim, Chong Jin Kim, Jung Han Yoon, Tae Hoon Ahn, Seung-Jea Tahk, Wook Sung Chung, Ki Bae Seung, Seung Jung Park, Other Korea Acute Myocardial infarction Registry Investigators